En behandlingsrelateret stigning i incidensen af nyretumorer blev ikke observeret i de orale carcinogenicitetsforsøg med Wistar- rotter (Wiga) eller hos Swiss- mus, som modtog oral risperidon.
The increase in mortality in patients treated with furosemide plus risperidone was observed in two of the four clinical trials.